- cafead Oct 27, 2022 at 10:53: AM
via Medable has launched a new patient-first offering that aids life sciences firms in boosting patient access, enrolment, and retention in oncology trials.
An end-to-end suite, the offering comprises pre-built and verified decentralised clinical trial (DCT) applications such as Total Consent and Televisit, a wide-ranging eCOA oncology library, and protocol design consultation.
article source
An end-to-end suite, the offering comprises pre-built and verified decentralised clinical trial (DCT) applications such as Total Consent and Televisit, a wide-ranging eCOA oncology library, and protocol design consultation.
article source